Xenotech, MultiCell Technologies Inc. (MUCL) Licensee, Presents Cell Lines At 7th Annual ISSX Meeting
10/19/2005 5:10:33 PM
MultiCell Technologies, Inc. (OTCBB:MUCL) announced today that XenoTech LLC, MultiCell's marketing and manufacturing licensee, is presenting MultiCell's immortalized liver cell lines at the 7th Annual International Society for the Study of Xenobiotics Meeting in Vancouver, Canada August 29 to Sept. 2. Dr. Andrew Parkinson, CEO, Kammie Settle, Marketing and Customer Service Manager, Jeff Shannon, Services Support Specialist, Maciej Czerwinski, Ph.D., Senior Scientist, and other key XenoTech personnel are present. XenoTech is featuring MultiCell's Fa2n-4 and EA1C-35 immortalized human hepatocyte lines at Booth 211. XenoTech's Japanese distributor, Nosan, also has personnel at the booth.